From Research to Innovation
To achieve our purpose of improving quality of life for patients, our mission includes bridging the gap between new knowledge and existing therapies and transforming scientific advances into therapeutic and diagnostic innovations for unmet needs.
Building on our preclinical and clinical expertise and resources, our pipeline consists of 380 solutions at various stages of development, including 90 innovations which are direct result of the research work carried out by our teams.
The Innovation and Technology Transfer Department’s mission is to work with our ecosystem of partners and experts to transform our research results into biomedical innovations.
What Imagine offers companies
Research and Innovation for Industry: Tremplin Carnot status
Imagine has been granted Tremplin Carnot status. As a member of the Carnot Network, our institute is committed to facilitating, investigating and implementing R&D projects with industry partners according to best practices in our sector.
Pipeline, partnerships, patents, licenses and start-ups: here are some of our innovation and technology transfer success stories.
Springboard, Imagine’s Accelerator
Springboard is Imagine’s dedicated initiative to provide funding and expertise for projects in genetic rare diseases. It’s goal is to maximize the chances of bringing innovations from the lab to the bedside in order to best help patients.
Lab-in-labs Innovation Platform
Lab-in-labs hosts industry partners in close proximity to researchers and doctors at Imagine to facilitate partnership research.
At Imagine, we want to make sure our research results are transformed into medical solutions to benefit patients. We take part in clinical research projects to confirm the value of new approaches in human trials.
These projects deepen our understanding of diseases, test new diagnostic and therapeutic approaches, and are a required stage in drug development before requesting approval to market the drug and make it available for patients. Imagine Institute’s teams are currently involved in more than 290 clinical trials.
Bioentrepreneurs Launchpad Program
This program to train entrepreneurs and accelerate healthtech start-up projects is a valuable stepping stone to entrepreneurship and value creation in the biomedical sector.